1
2
*Address for Correspondence: Dr. Vijay Viswanathan, MD, PhD, FRCP (London), FRCP (Glasgow) Prof. M. Viswanathan Diabetes Research Centre, M.V. Hospital for Diabetes(WHO Collaborating Centre for Research, Education and Training in Diabetes),No. 4, Main Road, Royapuram, Chennai 600013, India. Tel.: +91-44-25954913; Fax: +91-44-25954919. E-mail: drvijay@mvdiabetes.com
Aim was to evaluate subjects with type 2 diabetes at risk of obstructive sleep apnoea (OSA) using Epworth Sleepiness Scale (ESS). A total of 436 subjects (M/F=273:163) were evaluated and categorised as those unlikely to have significant OSA (ESS score <10; absence of snoring) and likely to have significant OSA (ESS score ≥10; presence of snoring). Body mass index (BMI), HbA1c and micro- and macrovascular complications were recorded. Among 436 subjects, 242 were unlikely to have significant OSA, of which 20% were randomly selected (n=58; Group 1) and compared with subjects (8.3%) likely to have OSA (n=36; Group 2). In all, 50% in Group 2 and 36% in Group 1 had hypertension (P=0.27). In Group 2, 2.8% had BMI (kg/m2) <23, 5.6% had 23–23.9, 19.4% had 24–24.9, 25% were between 25 and 26.9, and 47.2% had ≥27. Diabetic subjects even with normal BMI were at risk of OSA and more likely to have macrovascular comorbidity.
Epworth Sleepiness Scale, Obstructive sleep apnoea, type 2 diabetes, BMI